碧迪医疗

Becton, Dickinson: 15min chart triggers Bollinger Bands Narrowing, KDJ Death Cross.

Becton, Dickinson

Carmax

Steven Romick's Portfolio Shifts: A Closer Look at Becton Dickinson & Co and FPA Crescent Fund

Citi Reiterates Buy Rating on Becton, Dickinson Post-Spinoff, Sets $233 Price Target

Becton Dickinson Gains Positive Outlook with Buy Rating and $233 Target: Focus on MedTech Operations

Goldman Sachs ActiveBeta World Low Vol Plus Equity ETF

Goldman Sachs Reduces Stake in Becton Dickinson & Co, Company Announces Dividend

Catalyst<ul> <li>A Bullish Engulfing pattern was observed on 20260119 which indicates a potential reversal in the downward trend for BDX.</li></ul>Risk<ul> <li>Technical indicators show that the market is in a weak state and we need to pay attention to the risk of decline.</li> <li>The overall fund flow trend is negative across all order sizes indicating outflows and reduced institutional confidence in BDX.</li> <li>Bearish signals are clearly dominant with 6 bearish signals recorded versus only 1 bullish signal in the recent period.</li></ul>

Key Factors

BDX hits an intraday high of $213.08, up 1.96% as of 16:17 ET.KLAS Research awarded BD leadership in medication management technologies for 2026.Q1 earnings guidance hints at $2.82 EPS, down 17.8% YoY but with mixed segment growth.

Recent Updates

BDX News